{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:11:51Z","timestamp":1784819511180,"version":"3.55.0"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cancer and cardiovascular disease represent the two leading causes of morbidity and mortality worldwide. Women continue to enjoy a greater life expectancy than men. However, this comes at a cost with more women developing diabetes, hypertension and coronary artery disease as they age. These traditional cardiovascular risk factors not only increase their lifetime risk of heart failure but also their overall risk of cancer. In addition to this, many of the cancers with female preponderance are treated with potentially cardiotoxic therapies, adding to their increased risk of developing heart failure. As a result, we are faced with a higher risk population, potentially suffering from both cancer and heart failure simultaneously. This is of particular concern given the coexistence of heart failure and cancer can confer a worse prognosis than either a single diagnosis of heart failure or cancer alone. This review article explores the intersection of heart failure and cancer in women at multiple levels, including traditional cardiovascular risk factors, cardiovascular toxicity derived from antineoplastic and radiation therapy, shared pathophysiology and HF as an oncogenic process. This article further identifies opportunities and strategies for intervention and optimisation, whilst highlighting the need for contemporary guidelines to better inform clinical practice.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1276141","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T05:06:18Z","timestamp":1709096778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The intersection of heart failure and cancer in women: a review"],"prefix":"10.3389","volume":"11","author":[{"given":"Sara","family":"Tyebally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hui","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderonke","family":"Abiodun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Dalakoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po Fun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Yang","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.0336032018","article-title":"Linking heart failure to cancer","volume":"138","author":"Bertero","year":"","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/s12885-021-08716-5","article-title":"Cardiovascular disease in women with breast cancer\u2014a nationwide cohort study","volume":"21","author":"Jakobsen","year":"2021","journal-title":"BMC Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jnci\/djy218","article-title":"The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study","volume":"111","author":"Abdel-Qadir","year":"2019","journal-title":"JNCI J Natl Cancer Inst"},{"key":"B7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygyno.2022.08.014","article-title":"Cardiovascular disease diagnoses among older women with endometrial cancer","volume":"167","author":"Anderson","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","article-title":"The risk of cardiovascular disease following breast cancer by Framingham risk score","volume":"170","author":"Gernaat","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","article-title":"Patients with heart failure have an increased risk of incident cancer","volume":"62","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ejhf.472","article-title":"Incidence of cancer in patients with chronic heart failure: a long-term follow-up study","volume":"18","author":"Banke","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaccao.2021.11.007","article-title":"Cancer incidence and mortality according to Pre-existing heart failure in a community-based cohort","volume":"4","author":"Bertero","year":"2022","journal-title":"JACC CardioOncology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"658726","DOI":"10.3389\/fcvm.2021.658726","article-title":"Women with diabetes are at increased relative risk of heart failure compared to men: insights from UK biobank","volume":"8","author":"Chadalavada","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/COC.0b013e3181e1d0c0","article-title":"Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity","volume":"34","author":"Brunello","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/jdi.13231","article-title":"Prevalence of diabetes in Japanese patients with cancer","volume":"11","author":"Saito","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canep.2017.05.010","article-title":"Impact of comorbidity on survival by tumour location: breast, colorectal and lung cancer (2000\u20132014)","volume":"49","author":"Par\u00e9s-Badell","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1038\/s41598-019-44969-8","article-title":"The effects of comorbidity on colorectal cancer mortality in an Australian cancer population","volume":"9","author":"Pule","year":"2019","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin\u2013angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/jcm9103346","article-title":"Hypertensive cardiotoxicity in cancer treatment\u2014systematic analysis of adjunct, conventional chemotherapy, and novel therapies\u2014epidemiology, incidence, and pathophysiology","volume":"9","author":"Chung","year":"2020","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1038\/srep44877","article-title":"Hypertension and breast cancer risk: a systematic review and meta-analysis","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1008946825313","article-title":"Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)","volume":"11","author":"Weiderpass","year":"2000","journal-title":"Cancer Causes Control"},{"key":"B28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/aje\/kwq006","article-title":"Metabolic syndrome and endometrial carcinoma","volume":"171","author":"Bjorge","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.HYP.34.2.320","article-title":"Hypertension and hormone-related neoplasms in women","volume":"34","author":"Soler","year":"1999","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/s0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the cardiovascular health study","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1136\/hrt.72.2_suppl.s3","article-title":"Changing epidemiological features of cardiac failure","volume":"72","author":"Kannel","year":"1994","journal-title":"Br Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archinte.1993.00410090025004","article-title":"Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data","volume":"153","author":"Kronmal","year":"1993","journal-title":"Arch Intern Med"},{"key":"B34","first-page":"3700","article-title":"Dietary fat and its relationship to large bowel cancer","volume":"41","author":"Reddy","year":"1981","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0304-3835(95)04073-0","article-title":"Promotion of colon carcinogenesis through increasing lipid peroxidation induced in rats by a high cholesterol diet","volume":"100","author":"Tseng","year":"1996","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am J Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.ajpath.2014.03.006","article-title":"Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo","volume":"184","author":"Pelton","year":"2014","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.amjmed.2005.04.013","article-title":"Incidence and hospital death rates associated with heart failure: a community-wide perspective","volume":"118","author":"Goldberg","year":"2005","journal-title":"Am J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function","volume":"43","author":"Hogg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br J Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","journal-title":"Int J Obes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1177\/2047487319891603","article-title":"Women, obesity, and the incidence of heart failure: an uncertainty that has begun to be solved","volume":"27","author":"Jim\u00e9nez-Navarro","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Hear Fail"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e006539","DOI":"10.1161\/CIRCHEARTFAILURE.119.006539","article-title":"Sex-related differences in heart failure with preserved ejection fraction","volume":"12","author":"Dewan","year":"2019","journal-title":"Circ Hear Fail"},{"key":"B47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacc.2018.09.081","article-title":"Differential impact of heart failure with reduced ejection fraction on men and women","volume":"73","author":"Dewan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metab Clin Exp"},{"key":"B49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/ijc.23943","article-title":"Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-A meta-analysis","volume":"124","author":"Suzuki","year":"2009","journal-title":"Int J Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5493\/wjem.v3.i3.26","article-title":"Interplay of adipokines and myokines in cancer pathophysiology: emerging therapeutic implications","volume":"3","author":"Dalamaga","year":"2013","journal-title":"World J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.3390\/cancers14194565","article-title":"The association between smoking and mortality in women with breast cancer: a real-world database analysis","volume":"14","author":"Lai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.12225","article-title":"Exercise and heart failure: an update","volume":"5","author":"Cattadori","year":"2018","journal-title":"ESC Hear Fail"},{"key":"B56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/CIRCHEARTFAILURE.112.000054","article-title":"Physical fitness and risk for heart failure and coronary artery disease","volume":"6","author":"Berry","year":"2013","journal-title":"Circ Heart Fail"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1001\/jama.2009.681","article-title":"Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis","volume":"301","author":"Kodama","year":"2009","journal-title":"JAMA"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1056\/NEJMoa042135","article-title":"Adiposity as compared with physical activity in predicting mortality among women","volume":"351","author":"Hu","year":"2004","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.mcna.2004.03.003","article-title":"Heart failure in women","volume":"88","author":"Lund","year":"2004","journal-title":"Med Clin North Am"},{"key":"B60","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10654-017-0231-5","article-title":"Myocardial infarction and future risk of cancer in the general population\u2014the Troms\u00f8 study","volume":"32","author":"Rinde","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","article-title":"Heart failure after myocardial infarction is associated with increased risk of cancer","volume":"68","author":"Hasin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"B66","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/BF00686009","article-title":"Variability in the pharmacokinetics of epirubicin: a population analysis","volume":"29","author":"Wade","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF00685796","article-title":"Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry","volume":"36","author":"Dobbs","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.bjc.6690019","article-title":"Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein","volume":"79","author":"van","year":"1999","journal-title":"Br J Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1002\/cncr.33112","article-title":"Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16 INK4a and frailty","volume":"126","author":"Smitherman","year":"2020","journal-title":"Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","article-title":"Radiation-induced heart disease: pathologic abnormalities and putative mechanisms","volume":"5","author":"Taunk","year":"2015","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40959-020-00067-7","article-title":"Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin's Lymphoma: a systematic review","volume":"6","author":"Khalid","year":"2020","journal-title":"Cardio-Oncology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15420\/ecr.2015.10.01.19","article-title":"Chemotherapy-related cardiomyopathy","volume":"10","author":"Piper","year":"2015","journal-title":"Eur Cardiol Rev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-030-43032-0_15","article-title":"Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention","volume":"1257","author":"Bhagat","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan J","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"B78","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/jcdd9030066","article-title":"Cardiotoxicity of non-anthracycline cancer chemotherapy agents","volume":"9","author":"Briasoulis","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijcard.2020.05.077","article-title":"Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: emphasis on ponatinib","volume":"316","author":"Singh","year":"2020","journal-title":"Int J Cardiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cbi.2016.08.006","article-title":"Progress on the cardiotoxicity of sunitinib: prognostic significance, mechanism and protective therapies","volume":"257","author":"Yang","year":"2016","journal-title":"Chem Biol Interact"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1179546819866445","DOI":"10.1177\/1179546819866445","article-title":"Cancer therapy-related cardiac dysfunction: an overview for the clinician","volume":"13","author":"Perez","year":"2019","journal-title":"Clin Med Insights Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11936-020-00867-1","article-title":"Cardiotoxicity of contemporary anticancer immunotherapy","volume":"22","author":"Dal\u2019bo","year":"2020","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41698-018-0056-z","article-title":"Cardiotoxicity with vascular endothelial growth factor inhibitor therapy","volume":"2","author":"Touyz","year":"2018","journal-title":"npj Precis Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1073\/pnas.0408593102","article-title":"A survey of homozygous deletions in human cancer genomes","volume":"102","author":"Cox","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature08801","article-title":"Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice","volume":"464","author":"Visel","year":"2010","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaccao.2020.09.006","article-title":"Genetics of anthracycline cardiomyopathy in cancer survivors","volume":"2","author":"Bhatia","year":"2020","journal-title":"JACC CardioOncology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41598-017-00075-1","article-title":"Candidate gene association studies of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis","volume":"7","author":"Leong","year":"2017","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jaccao.2019.09.008","article-title":"Increased cancer prevalence in peripartum cardiomyopathy","volume":"1","author":"Pfeffer","year":"2019","journal-title":"JACC CardioOncology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s11886-023-01967-7","article-title":"Tailored to a woman's heart: gender cardio-oncology across the lifespan","volume":"25","author":"Chen","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1001\/jamacardio.2021.3490","article-title":"Premature menopause and 10-year risk prediction of atherosclerotic cardiovascular disease","volume":"6","author":"Freaney","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaccao.2023.07.002","article-title":"Tracing the pathways from cardiovascular disease to cancer","volume":"5","author":"Abraham","year":"2023","journal-title":"JACC CardioOncology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","article-title":"Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment","volume":"25","author":"Tulotta","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"Heart failure stimulates tumor growth by circulating factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature10368","article-title":"A stress response pathway regulates DNA damage through \u03b22-adrenoreceptors and \u03b2-arrestin-1","volume":"477","author":"Hara","year":"2011","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaccao.2023.10.002","article-title":"Heart failure post-myocardial infarction promotes mammary tumor growth through the NGF-TRKA pathway","volume":"6","author":"Tani","year":"2023","journal-title":"JACC CardioOncology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-018-0105-x","article-title":"Can heart failure cause cancer?","volume":"16","author":"Richards","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fcvm.2018.00062","article-title":"Antiinflammatory therapy in clinical care: the CANTOS trial and beyond","volume":"5","author":"Aday","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jacc.2019.05.045","article-title":"Clonal hematopoiesis of indeterminate potential reshapes age-related CVD","volume":"74","author":"Khetarpal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.ahj.2013.08.029","article-title":"Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the get with the guideline-heart failure registry","volume":"166","author":"Hsich","year":"2013","journal-title":"Am Heart J"},{"key":"B105","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.amjcard.2012.04.033","article-title":"Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure","volume":"110","author":"Egstrup","year":"2012","journal-title":"Am J Cardiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/J.ECHO.2008.09.009","article-title":"American society of echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography","volume":"21","author":"Mulvagh","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"B107","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/FJC.0000000000001281","article-title":"Multimodality imaging for cardiotoxicity: state of the art and future perspectives","volume":"80","author":"Artico","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/cncr.21876","article-title":"Breast cancer incidence in U.S. Radiologic technologists","volume":"106","author":"Doody","year":"2006","journal-title":"Cancer"},{"key":"B109","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1590\/S1415-475738420150019","article-title":"Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer","volume":"38","author":"Borrego-Soto","year":"2015","journal-title":"Genet Mol Biol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.siny.2013.11.009","article-title":"Carcinogenic risks of prenatal ionizing radiation","volume":"19","author":"Brent","year":"2014","journal-title":"Semin Fetal Neonatal Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/ehjci\/jeaa345","article-title":"Role of cardiovascular magnetic resonance imaging in cardio-oncology","volume":"22","author":"Saunderson","year":"2021","journal-title":"Eur Hear J Cardiovasc Imaging"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/J.JCMG.2018.07.022","article-title":"Anatomical and functional computed tomography for diagnosing hemodynamically significant coronary artery disease: a meta-analysis","volume":"12","author":"Celeng","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B113","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jacc.2009.02.066","article-title":"Heart failure in women: a need for prospective data","volume":"54","author":"Hsich","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/S0140-6736(02)11601-1","article-title":"Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international survey","volume":"360","author":"Cleland","year":"2002","journal-title":"Lancet"},{"key":"B116","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults A report of the American college of cardiology foundation\/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/s0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2\u2009\u00d7\u20092 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol","volume":"37","author":"Gulati","year":"2016","journal-title":"Eur Heart J"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","article-title":"Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials","volume":"110","author":"Young","year":"2004","journal-title":"Circulation"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"Valsartan heart failure trial investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol heart failure study group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/01.cir.103.3.375","article-title":"Sex differences in the prognosis of congestive heart failure: results from the cardiac insufficiency bisoprolol study (CIBIS II)","volume":"103","author":"Simon","year":"2001","journal-title":"Circulation"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/01.cir.0000012546.20194.33","article-title":"Metoprolol CR\/XL in female patients with heart failure: analysis of the experience in metoprolol extended-release randomized intervention trial in heart failure (MERIT-HF)","volume":"105","author":"Ghali","year":"2002","journal-title":"Circulation"},{"key":"B127","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.112.000055","article-title":"Cardioprotective effect of \u03b2-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy","volume":"6","author":"Seicean","year":"2013","journal-title":"Circ Hear Fail"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","article-title":"Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study","volume":"167","author":"Kaya","year":"2013","journal-title":"Int J Cardiol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ejhf.196","article-title":"Protective effects of spironolactone against anthracycline-induced cardiomyopathy","volume":"17","author":"Akpek","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B132","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet (London, England)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"B135","doi-asserted-by":"publisher","first-page":"691907","DOI":"10.3389\/fcvm.2021.691907","article-title":"Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis","volume":"8","author":"Gager","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jchf.2022.03.006","article-title":"Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines","volume":"10","author":"Gongora","year":"2022","journal-title":"JACC Hear Fail"},{"key":"B137","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jaccao.2023.05.013","article-title":"The association of metformin with heart failure in patients with diabetes Mellitus receiving anthracycline chemotherapy","volume":"5","author":"Onoue","year":"2023","journal-title":"JACC CardioOncology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40264-023-01305-4","article-title":"The effect of metformin on chemotherapy-induced toxicities in non-diabetic breast cancer patients: a randomised controlled study","volume":"46","author":"Serageldin","year":"2023","journal-title":"Drug Saf"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/eurheartj\/ehv264","article-title":"Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT?: figure 1","volume":"36","author":"Cleland","year":"2015","journal-title":"Eur Heart J"},{"key":"B140","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/europace\/euu205","article-title":"Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure","volume":"17","author":"Linde","year":"2015","journal-title":"Europace"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1136\/heartjnl-2015-307634","article-title":"Individual patient data network meta-analysis of mortality effects of implantable cardiac devices","volume":"101","author":"Woods","year":"2015","journal-title":"Heart"},{"key":"B142","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/CIRCULATIONAHA.108.793463","article-title":"Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy","volume":"119","author":"Peterson","year":"2009","journal-title":"Circulation"},{"key":"B144","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.meddos.2014.05.005","article-title":"Treatment approach, delivery, and follow-up evaluation for cardiac rhythm disease management patients receiving radiation therapy: retrospective physician surveys including chart reviews at numerous centers","volume":"39","author":"Gossman","year":"2014","journal-title":"Med Dosim"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","article-title":"National heart foundation of Australia and cardiac society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018","volume":"27","author":"Atherton","year":"2018","journal-title":"Heart Lung Circ"},{"key":"B146","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","article-title":"Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials","volume":"8","author":"Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"key":"B147","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1200\/JCO.2011.40.8922","article-title":"Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis","volume":"31","author":"Faller","year":"2013","journal-title":"J Clin Oncol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1534735418820447","DOI":"10.1177\/1534735418820447","article-title":"Influence of a multimodal and multimodal-aerobic therapy concept on health-related quality of life in breast cancer survivors","volume":"18","author":"Poier","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"B149","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jocn.15114","article-title":"The experience of cancer-related fatigue, exercise and exercise adherence among women breast cancer survivors: insights from focus group interviews","volume":"29","author":"Kim","year":"2020","journal-title":"J Clin Nurs"},{"key":"B150","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41371-020-0391-8","article-title":"Hypertension management in cardio-oncology","volume":"34","author":"Essa","year":"2020","journal-title":"J Hum Hypertens"},{"key":"B151","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s1071-9164(97)90022-1","article-title":"The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease","volume":"3","author":"Kjekshus","year":"1997","journal-title":"J Card Fail"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e018393","DOI":"10.1161\/JAHA.119.018393","article-title":"Statin exposure and risk of heart failure after anthracycline- or trastuzumab-based chemotherapy for early breast cancer: a propensity score\u2012matched cohort study","volume":"10","author":"Abdel-Qadir","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/sj.bjc.6602611","article-title":"Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study","volume":"92","author":"Swerdlow","year":"2005","journal-title":"Br J Cancer"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1200\/JCO.2008.17.5935","article-title":"Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer","volume":"27","author":"Srokowski","year":"2009","journal-title":"J Clin Oncol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","article-title":"Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis","volume":"29","author":"Peairs","year":"2011","journal-title":"J Clin Oncol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00125-012-2525-1","article-title":"Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence","volume":"55","author":"Johnson","year":"2012","journal-title":"Diabetologia"},{"key":"B157","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10549-014-2985-8","article-title":"Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes","volume":"145","author":"Tseng","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B159","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.15420\/ecr.2021.45","article-title":"Chest pain in the cancer patient","volume":"17","author":"Tyebally","year":"2022","journal-title":"Eur Cardiol Rev"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1276141\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T05:06:29Z","timestamp":1709096789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1276141\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":159,"alternative-id":["10.3389\/fcvm.2024.1276141"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1276141","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"article-number":"1276141"}}